Literature DB >> 20087783

Hepatocellular carcinomas in cirrhotic and noncirrhotic human livers share angiogenic characteristics.

Wenjiao Zeng1, Annette S H Gouw, Marius C van den Heuvel, Grietje Molema, Sibrand Poppema, Eric J van der Jagt, Koert P de Jong.   

Abstract

BACKGROUND: The antiangiogenic drug sorafenib has been shown to be an effective treatment for hepatocellular carcinoma (HCC) in patients with liver cirrhosis. It might also be effective in noncirrhotic HCC provided that the angiogenic properties of both tumor types are comparable. The aim of this study is to compare endothelial cell dynamics, microvessel density (MVD), and vessel maturation as indirect markers of angiogenesis in human HCC in cirrhotic and noncirrhotic livers.
MATERIALS AND METHODS: In a tertiary care setting, 70 consecutive HCC tumors were analyzed for endothelial cell dynamics. CD34 was applied to identify tumor microvessels, double immunolabeling Ki67/CD34 and activated caspase-3/CD34 to assess endothelial cell proliferation and apoptosis, and alpha-smooth muscle actin/CD34 for pericyte coverage. These characteristics were compared in cirrhotic (n = 33) and noncirrhotic HCCs (n = 37). Microvessel density was correlated with radiological signs of hypervascularity as obtained with dynamic four-phase CT scans during the arterial and portal phase of contrast enhancement.
RESULTS: Microvessels in cirrhotic and noncirrhotic HCC were mainly mature. In both groups endothelial cell turnover was low and MVD was not different. There was no correlation between MVD and venous invasion, tumor size, and turnover of tumor cells or endothelial cells. MVD was negatively correlated with contrast washout in the portal venous phase of CT scanning. In transplanted patients, MVD was not correlated with survival, whereas in patients after liver resection a high MVD was associated with a better prognosis.
CONCLUSION: Angiogenic characteristics of HCC in cirrhotic and noncirrhotic livers have a remarkable similarity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20087783      PMCID: PMC2868164          DOI: 10.1245/s10434-009-0900-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  35 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

Review 2.  Perfusion imaging of the liver: current challenges and future goals.

Authors:  Pari V Pandharipande; Glenn A Krinsky; Henry Rusinek; Vivian S Lee
Journal:  Radiology       Date:  2005-03       Impact factor: 11.105

Review 3.  Angiogenesis and hepatocellular carcinoma.

Authors:  David Semela; Jean-François Dufour
Journal:  J Hepatol       Date:  2004-11       Impact factor: 25.083

4.  Endothelial cell apoptosis in the context of quantification of angiogenesis in solid human adenocarcinomas: a novel double immunolabelling technique to identify endothelial cell apoptosis.

Authors:  Koert P de Jong; Peter B Vermeulen; Eric van Marck; Marcel Boot; Annette S H Gouw
Journal:  Eur J Cancer       Date:  2005-12-05       Impact factor: 9.162

Review 5.  Angiogenesis in life, disease and medicine.

Authors:  Peter Carmeliet
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

6.  Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver.

Authors:  Y N Park; C P Yang; G J Fernandez; O Cubukcu; S N Thung; N D Theise
Journal:  Am J Surg Pathol       Date:  1998-06       Impact factor: 6.394

7.  Correlative study of angiogenesis and dynamic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma.

Authors:  B Wang; Z Q Gao; X Yan
Journal:  Acta Radiol       Date:  2005-07       Impact factor: 1.990

8.  Neoangiogenesis and sinusoidal capillarization in hepatocellular carcinoma: correlation between dynamic CT and density of tumor microvessels.

Authors:  Chan Kyo Kim; Jae Hoon Lim; Cheol Keun Park; Dongil Choi; Hyo Keun Lim; Won Jae Lee
Journal:  Radiology       Date:  2005-11       Impact factor: 11.105

9.  Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver.

Authors:  Joanna-W Ho; Ronnie-T Poon; Chris-K Sun; Wei-Cheng Xue; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

Review 10.  Differentiation and definition of vascular-targeted therapies.

Authors:  Dietmar W Siemann; Michael C Bibby; Graham G Dark; Adam P Dicker; Ferry A L M Eskens; Michael R Horsman; Dieter Marmé; Patricia M Lorusso
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

View more
  9 in total

Review 1.  Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Mei Wang
Journal:  World J Hepatol       Date:  2015-01-27

2.  Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer.

Authors:  Dongrong Situ; Jian Wang; Yun Ma; Zhihua Zhu; Yi Hu; Hao Long; Tiehua Rong
Journal:  Med Oncol       Date:  2010-11-30       Impact factor: 3.064

3.  Chemoembolization of intermediate stage hepatocellular carcinomas: results from a Nordic tertiary liver cancer center.

Authors:  Kasper J Andersen; Henning Grønbaek; Gerda Elisabeth Villadsen; Anders Riegels Knudsen; Peter Ott; Hendrik Vildstrup; Dennis Tønner Nielsen; Arindam Bharadwaz
Journal:  Indian J Gastroenterol       Date:  2013-12-04

4.  Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinoma.

Authors:  Wenjiao Zeng; Anke van den Berg; Sippie Huitema; Annette S H Gouw; Grietje Molema; Koert P de Jong
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

5.  Clinical and prognostic significance of MUC1 expression in patients with esophageal squamous cell carcinoma after radical resection.

Authors:  Zhi-Gang Sun; Li Yu; Wei Gao; Zhou Wang; Liang-Ming Zhu
Journal:  Saudi J Gastroenterol       Date:  2018 May-Jun       Impact factor: 2.485

6.  Effect of KI-67 positive cellular index on prognosis after hepatectomy in Barcelona Clinic Liver Cancer stage A and B hepatocellular carcinoma with microvascular invasion.

Authors:  Hong-Hao Li; Lu-Nan Qi; Liang Ma; Zu-Shun Chen; Bang-De Xiang; Le-Qun Li
Journal:  Onco Targets Ther       Date:  2018-08-10       Impact factor: 4.147

7.  A Pretreatment CT Model Predicts Survival Following Chemolipiodolization in Patients With Hepatocellular Carcinoma.

Authors:  Yijun Zhang; Shuping Qu; Wanwan Yi; Jian Zhai; Xiaobing Zhang; Lixin Wei; Wan Yee Lau; Mengchao Wu; Feng Shen; Hengwei Fan; Dong Wu
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

Review 8.  Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.

Authors:  Aakash Desai; Sonia Sandhu; Jin-Ping Lai; Dalbir Singh Sandhu
Journal:  World J Hepatol       Date:  2019-01-27

Review 9.  Evaluation of Intra-Tumoral Vascularization in Hepatocellular Carcinomas.

Authors:  Qi Zhang; Jiajun Wu; Xueli Bai; Tingbo Liang
Journal:  Front Med (Lausanne)       Date:  2020-10-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.